av/pliant-therapeutics--big.svg

COM:PLIANTRX

Pliant Therapeutics

  • Stock

USD

Last Close

12.85

22/11 21:00

Market Cap

669.01M

Beta: -

Volume Today

586.02K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
0.50
-
average payables
1.91M
-
1.64M
14.45%
2.50M
52.58%
2.28M
8.87%
3.06M
34.28%
average receivables
3.94M
-
8.37M
112.39%
5.72M
31.67%
2.07M
63.76%
1.03M
50.18%
book value per share
-0.05
-
-0.02
62.70%
13.26
66,651.58%
5.55
58.13%
7.46
34.30%
0.01
99.89%
capex per share
-0.14
-
-0.04
68.61%
-0.07
62.54%
-0.05
24.09%
-0.04
23.11%
-0.00
99.96%
capex to depreciation
-3.49
-
-0.87
75.17%
-1.17
35.02%
-1.27
8.79%
-0.97
24.12%
-0.50
48.18%
capex to operating cash flow
0.08
-
0.35
327.48%
0.04
88.27%
0.03
37.02%
0.02
28.16%
0.01
57.44%
capex to revenue
-0.02
-
-0.04
116.82%
-0.26
604.02%
-0.18
29.54%
-0.58
220.77%
cash per share
3.69
-
4.71
27.53%
12.97
175.55%
5.60
56.86%
7.88
40.86%
0.01
99.89%
days of inventory on hand
days payables outstanding
days sales outstanding
47.25
-
81.72
72.96%
100.31
22.76%
77.86
22.38%
debt to assets
0.01
-
0.00
52.74%
0.00
74.32%
0.03
3,295.98%
0.05
38.70%
0.02
50.77%
debt to equity
-0.60
-
-1.02
71.48%
0.00
100.10%
0.04
3,514.78%
0.05
39.66%
0.02
52.42%
dividend yield
earnings yield
-0.09
-
0.00
100.46%
-0.08
20,699.17%
-0.04
54.85%
-0.15
304.28%
-0.00
99.90%
enterprise value
291.24M
-
379.61M
30.34%
434.34M
14.42%
439.46M
1.18%
794.30M
80.75%
1.06T
133,773.11%
enterprise value over ebitda
-9.63
-
-3.22K
33,312.93%
-10.43
99.68%
-21.99
110.82%
-6.48
70.52%
-5.77K
88,979.10%
ev to operating cash flow
-10.28
-
-138.04
1,242.67%
-11.65
91.56%
-5.83
50.02%
-8.39
44.10%
-9.14K
108,772.78%
ev to sales
6.65
-
10.39
56.10%
58.04
458.76%
82.01
41.31%
673.01K
820,508.24%
free cash flow per share
-1.86
-
-0.17
90.84%
-1.82
968.54%
-2.16
18.76%
-2.29
6.26%
-0.00
99.91%
free cash flow yield
-0.09
-
-0.01
90.84%
-0.08
901.76%
-0.16
99.88%
-0.12
25.79%
-0.00
99.91%
graham net net
-0.37
-
-0.51
39.00%
12.72
2,581.62%
5.02
60.52%
7.03
40.04%
0.01
99.89%
graham number
1.48
-
0.06
95.85%
23.57
38,140.04%
7.90
66.48%
22.03
178.82%
0.02
99.90%
income quality
0.94
-
4.36
365.79%
0.90
79.41%
0.78
13.56%
0.77
1.07%
0.72
6.01%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
-73.48
-
-160.81
118.85%
-7.65
95.24%
interest debt per share
0.03
-
0.02
36.04%
0.01
34.81%
0.21
1,470.86%
0.40
89.76%
0.00
99.85%
inventory turnover
invested capital
-0.60
-
-1.02
71.48%
0.00
100.10%
0.04
3,514.78%
0.05
39.66%
0.02
52.42%
market cap
351.66M
-
464.97M
32.22%
484.94M
4.29%
483.93M
0.21%
812.17M
67.83%
1.06T
130,833.90%
net current asset value
-5.68M
-
-7.60M
33.83%
278.29M
3,762.18%
187.28M
32.70%
303.04M
61.81%
466.92M
54.08%
net debt to ebitda
2.00
-
723.42
36,115.06%
1.22
99.83%
2.23
83.14%
0.15
93.45%
0.28
93.11%
net income per share
-1.83
-
0.01
100.46%
-1.86
22,072.44%
-0.50
73.17%
-2.89
478.87%
-0.00
99.90%
operating cash flow per share
-1.72
-
-0.13
92.66%
-1.75
1,286.14%
-2.10
20.53%
-2.25
7.02%
-0.00
99.91%
payables turnover
receivables turnover
7.73
-
4.47
42.18%
3.64
18.54%
4.69
28.83%
research and ddevelopement to revenue
0.83
-
1.58
90.71%
10.24
547.00%
10.01
2.27%
80.88
708.12%
return on tangible assets
-0.46
-
0.00
100.34%
-0.13
8,755.57%
-0.08
39.81%
-0.35
328.09%
-0.32
9.09%
revenue per share
2.61
-
1.96
25.04%
0.21
89.22%
0.23
9.12%
0.00
99.99%
roe
34.33
-
-0.43
101.24%
-0.14
66.98%
-0.09
35.93%
-0.39
331.03%
-0.34
12.14%
roic
-187.90
-
0.80
100.42%
-0.14
117.64%
-0.09
39.47%
-0.37
339.78%
-0.38
1.24%
sales general and administrative to revenue
0.19
-
0.41
115.56%
3.64
781.30%
4.12
13.34%
36.66
788.84%
shareholders equity per share
-0.05
-
-0.02
62.70%
13.26
66,651.58%
5.55
58.13%
7.46
34.30%
0.01
99.89%
stock based compensation to revenue
0.03
-
0.09
190.54%
1.38
1,379.83%
2.33
69.28%
28.15
1,106.61%
tangible asset value
-882K
-
-435K
50.68%
283.06M
65,171.49%
199.06M
29.68%
313.34M
57.41%
473.58M
51.14%
tangible book value per share
-0.05
-
-0.02
62.70%
13.26
66,651.58%
5.55
58.13%
7.46
34.30%
0.01
99.89%
working capital
56.65M
-
103.73M
83.11%
279.15M
169.12%
192.61M
31.00%
316.40M
64.27%
476.98M
50.75%

All numbers in USD (except ratios and percentages)